Baldry Mark
SEC insider (Form 3/4/5 filer). CIK 0001644137. Chief Commercial Officer at X4 Pharmaceuticals, Inc (XFOR). 9 reported Form 4/5 transactions since Sep 2024; latest on May 16, 2025. Located in BOSTON, MA.
Companies Baldry Mark has filed insider reports for
- X4 Pharmaceuticals, Inc (XFOR): Officer, Chief Commercial Officer
Baldry Mark
CIK: 0001644137
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
X4 Pharmaceuticals, Inc
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 16, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect1K shares at avg. $2.48$3K - May 16, 2025XFOR
X4 Pharmaceuticals, Inc
PurchaseDirect1K shares at avg. $2.48$3K - Feb 12, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect600K shares- - Jan 24, 2025XFOR
X4 Pharmaceuticals, Inc
SaleDirect29.2K shares at avg. $0.45$13K - Jan 23, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect74.8K shares- - Nov 15, 2024XFOR
X4 Pharmaceuticals, Inc
PurchaseDirect13.4K shares at avg. $0.34$5K - Oct 7, 2024XFOR
X4 Pharmaceuticals, Inc
SaleDirect11.1K shares at avg. $0.58$7K - Oct 4, 2024XFOR
X4 Pharmaceuticals, Inc
AwardDirect34.9K shares- - May 17, 2024XFOR
X4 Pharmaceuticals, Inc
PurchaseDirect21.6K shares at avg. $0.68$15K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 16, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 1,032 | $2.48 | $2,561 | Direct |
| May 16, 2025 | XFOR X4 Pharmaceuticals, Inc | Purchase | 1,032 | $2.48 | $2,561 | Direct |
| Feb 12, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 600,000 | - | - | Direct |
| Jan 24, 2025 | XFOR X4 Pharmaceuticals, Inc | Sale | 29,159 | $0.45 | $13,241 | Direct |
| Jan 23, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 74,773 | - | $0 | Direct |
| Nov 15, 2024 | XFOR X4 Pharmaceuticals, Inc | Purchase | 13,404 | $0.34 | $4,598 | Direct |
| Oct 7, 2024 | XFOR X4 Pharmaceuticals, Inc | Sale | 11,127 | $0.58 | $6,506 | Direct |
| Oct 4, 2024 | XFOR X4 Pharmaceuticals, Inc | Award | 34,946 | - | $0 | Direct |
| May 17, 2024 | XFOR X4 Pharmaceuticals, Inc | Purchase | 21,646 | $0.68 | $14,654 | Direct |
1-9 of 9 transactions